NOBEL BIOCARE MEXICO supplier risk profile Q1-2026: sourcing footprint and compliance assessment
NOBEL BIOCARE MEXICO recorded 53 shipments in Q1 2026 across two suppliers and two countries. The importer sourced primarily from Israel, which accounted for 94.3% of shipments, with the remainder from the United States. ALPHA-BIO TEC (Israel) was the dominant supplier with 50 shipments, followed by NOBEL BIOCARE (US) with 3 shipments. Medical devices (HS Chapter 90) dominated the product mix, representing approximately 94.4% of total shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
NOBEL BIOCARE MEXICO shows no matches on international sanctions watchlists and has no suppliers with documented forced-labor exposure under the UFLPA framework. The importer's compliance profile presents no identified red flags in these categories.
2 distinct tier-1 suppliers in Q1 2026
| ALPHA-BIO TEC | Israel | 50 |
| NOBEL BIOCARE | United States | 3 |
Share of Q1 2026 inbound shipments by source country
2 tier-2 + 2 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.